Blood Products Advisory Committee

Blood Products Advisory Committee Committee Meeting September 20 from 8:00 a.m. to 5:00 p.m. (Day 1 of 2) Agenda: On September 20, 2012, the committee will discuss hepatitis E virus and blood transfusion safety. In the afternoon, the committee will discuss Octapharma’s biologics license application for Pooled Plasma (Human, Solvent/Detergent Treated).